A pilot study of the immunological profile and efficacy of rituximab in muscle-specific kinase antibody-positive myasthenia gravis

A pilot study of the immunological profile and efficacy of rituximab in muscle-specific kinase antibody-positive myasthenia gravis

PurposeThis study summarized the clinical and immunological characteristics of patients with muscle-specific kinase (MuSK) antibody-positive myasthenia gravis (MG), compared their difference with acetylcholine receptor (AChR) antibody-positive MG, and evaluated the therapeutic efficacy of rituximab...

Full description

Saved in:
Bibliographic Details
Main Authors: Fengzhan Li, Zhouao Zhang, Tianyu Ma, Yuting Li, Luyao Su, Zhouyi Wang, Tiancheng Luo, Deyou Peng, Xinyan Guo, Mingjin Yang, Xue Du, Xiaoyu Huang, Yong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
muscle-specific kinase
myasthenia gravis
B lymphocyte
T lymphocyte
natural killer cell
rituximab
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1624038/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1624038/full

Similar Items